Abstract

Renin–angiotensin–aldosterone system (RAAS) plays important roles in regulating renal hemodynamics and functions, as well as in the pathophysiology of hypertension and renal disease. In the kidney, angiotensin II (Ang II) production is controlled by independent multiple mechanisms. 

Ang II is compartmentalized in the renal interstitial fluid with much higher concentrations than those existing in the circulation. Inappropriate activation of the intrarenal RAAS is an important contributor to the pathogenesis of hypertension and renal injury. 

It has been revealed that intrarenal Ang II levels are predominantly regulated by angiotensinogen and therefore, urinary angiotensinogen could be a biomarker for intrarenal Ang II generation. In addition, recent studies have demonstrated that aldosterone contributes to the progression of renal injury via direct actions on glomerular podocytes, mesangial cells, proximal tubular cells and tubulo-interstitial fibroblasts through the activation of locally expressed mineralocorticoid receptor. 

Thus, it now appears that intrarenal RAAS is independently regulated and its inappropriate activation contributes to the pathogenesis of the development of hypertension and renal disease. This short review article will focus on the independent regulation of the intrarenal RAAS with an emphasis on the specific role of angiotensinogen.

Nishiyama, A., Kobori, H. Independent regulation of renin–angiotensin–aldosterone system in the kidney. Clin Exp Nephrol22, 1231–1239 (2018). https://doi.org/10.1007/s10157-018-1567-1

IBL-America offers an array of ELISA kits applicable to the research regarding this pathway. These include, but are not limited to:

• Renin
• ACE
• Angiotensin I & II
• Angiotensinogen
• Aldosterone
• PRA

If you have any questions about the RAAS Pathway product offerings please contact us here.